Clinical Trial Update: Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Taxotere and Nanoxel M as neoadjuvant chemotherapy for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nanoxel M (docetaxel)
• Taxotere (docetaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED